Natera, Inc. SEC filings NTRA

Natera, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 11, 2022. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Natera, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Aug 7, 2026 —
10-Q Quarterly report Aug 7, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change
Jul 6, 2026 Jul 1, 2026
8-K/A Amended current report
Officer or director change
Jun 16, 2026 Jun 2, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2026 Jun 11, 2026
8-K Current report
Officer or director change
Jun 5, 2026 Jun 2, 2026
10-Q Quarterly report May 8, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 11, 2026
8-K Current report
Officer or director change
Apr 1, 2026 Mar 26, 2026
S-8 Employee stock plan registration Mar 2, 2026 —
10-K Annual report Feb 27, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Results of operations
Jan 12, 2026 Jan 11, 2026
S-3ASR Automatic shelf registration Dec 10, 2025 —
RW Filing Dec 10, 2025 —
S-8 Employee stock plan registration Dec 5, 2025 —
S-3 Shelf registration Dec 5, 2025 —
8-K Current report
Unregistered share sale, Other events
Dec 5, 2025 Dec 4, 2025
10-Q Quarterly report Nov 7, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
S-8 Employee stock plan registration Oct 21, 2025 —
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2025 Jun 12, 2025
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 12, 2025
8-K Current report
Officer or director change
Mar 12, 2025 Mar 6, 2025
S-8 Employee stock plan registration Feb 28, 2025 —
10-K Annual report Feb 28, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 12, 2025
8-K Current report
Officer or director change
Dec 6, 2024 Dec 2, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Other events
Jul 22, 2024 Jul 19, 2024
S-8 Employee stock plan registration Jul 16, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2024 Jun 12, 2024
DEFA14A Additional proxy material Jun 5, 2024 —
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 24, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 24, 2024 —
DEF 14A Proxy statement Apr 24, 2024 Jun 12, 2024
S-8 Employee stock plan registration Mar 1, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
8-K Current report
Other events
Jan 22, 2024 Jan 17, 2024
8-K Current report
Results of operations
Jan 9, 2024 Jan 9, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 8, 2023 Nov 8, 2023
8-K Current report
Material agreement, Other events
Sep 7, 2023 Sep 6, 2023
424B5 Prospectus supplement Sep 7, 2023 —
S-3ASR Automatic shelf registration Sep 6, 2023 —
10-Q Quarterly report Aug 4, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K Current report
Shareholder vote results
Jun 15, 2023 Jun 9, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Officer or director change
Apr 21, 2023 Apr 19, 2023
ARS Annual report to shareholders Apr 20, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 20, 2023 —
DEF 14A Proxy statement Apr 20, 2023 —
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
S-8 Employee stock plan registration Mar 1, 2023 —
10-K Annual report Mar 1, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 28, 2023 Feb 28, 2023
8-K Current report
Officer or director change
Feb 23, 2023 Feb 17, 2023
POSASR Filing Dec 6, 2022 —
8-K Current report
Material agreement, Other events
Nov 16, 2022 Nov 15, 2022
424B5 Prospectus supplement Nov 16, 2022 —
S-3ASR Automatic shelf registration Nov 15, 2022 —
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Officer or director change
Aug 15, 2022 Aug 11, 2022
10-Q Quarterly report Aug 5, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022

Showing 85 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
NTRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
Large accelerated filer
SEC CIK
1604821
Former names
Natera, Inc. (until Nov 5, 2026)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.